文献速递脊柱关节炎

银屑病关节炎女性妊娠结局与抗风湿治疗存在及时机的关系

Pregnancy Outcomes in Women With Psoriatic Arthritis in Relation to Presence and Timing of Antirheumatic Treatment.
PubMed 文献 · Arthritis Rheumatol · 2022-01-27

瑞典全国登记队列研究纳入921例银屑病关节炎(PsA)妊娠与9210例非PsA妊娠(2007–2017年,按母亲年龄、分娩年份和产次1:10匹配)。PsA妊娠早产(调整OR 1.69 [95%CI 1.27-2.24])和剖宫产(择期调整OR 1.77 [95%CI 1.43-2.20];急诊调整OR 1.42 [95%CI 1.10-1.84])风险升高。风险随抗风湿治疗存在、时机和类型而异,妊娠期接受抗风湿治疗者早产调整OR 2.30 [95%CI 1.49-3.56],妊娠期暴露生物制剂者早产调整OR 4.49 [95%CI 2.60-7.79],早产风险主要在首次妊娠中升高。

要点

  • PsA妊娠较非PsA妊娠早产和剖宫产风险升高。
  • 妊娠期抗风湿治疗者早产风险更高,生物制剂暴露者尤甚。
  • 早产风险主要在首次妊娠中升高,需个体化监测。

核心结论

  • 与非PsA妊娠相比,PsA妊娠早产和剖宫产风险主要在妊娠期接受抗风湿治疗者中升高,尤其是生物制剂治疗者。
  • 产次影响PsA女性早产风险,首次妊娠需特别关注。
  • PsA女性妊娠期应接受个体化监测。

研究设计与样本

  • 瑞典全国登记队列研究,纳入921例PsA妊娠和9210例非PsA妊娠(2007–2017年),按母亲年龄、分娩年份和产次1:10匹配。
  • 估计总体调整OR及95%CI,并按抗风湿治疗的存在、时机和类型分层。
  • 调整母亲体重指数、吸烟、教育水平和出生国家,早产结局另按产次分层。

主要发现

  • PsA妊娠女性较非PsA妊娠女性更肥胖、更常吸烟,且更常有孕前高血压和糖尿病诊断。
  • PsA妊娠 vs 非PsA妊娠:早产调整OR 1.69 [95%CI 1.27-2.24];择期剖宫产调整OR 1.77 [95%CI 1.43-2.20];急诊剖宫产调整OR 1.42 [95%CI 1.10-1.84]。
  • 妊娠期接受抗风湿治疗者(vs 非PsA)早产调整OR 2.30 [95%CI 1.49-3.56]。
  • 妊娠期暴露生物制剂者早产调整OR 4.49 [95%CI 2.60-7.79]。
  • 早产风险主要在首次妊娠中升高。

临床怎么用

  • 对PsA妊娠女性应个体化监测,尤其妊娠期接受抗风湿治疗(特别是生物制剂)者。
  • 首次妊娠的PsA女性应特别关注早产风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate pregnancy outcomes in relation to antirheumatic treatment before and during pregnancy, as a proxy of disease severity in pregnant women with psoriatic arthritis (PsA), compared to those without PsA. METHODS: Our study focused on a Swedish nationwide registry-based cohort study that included 921 PsA pregnancies and 9,210 non-PsA pregnancies occurring between 2007 and 2017 (matched 1:10 based on maternal age, year of delivery, and parity). We estimated adjusted odds ratios (ORs) overall, with 95% confidence intervals (95% CIs), and stratified by presence, timing, and type of antirheumatic treatment. Adjustments were made for maternal body mass index, smoking, education level, and country of birth. The outcome of preterm birth was also stratified by parity. RESULTS: Pregnant women with PsA versus those without PsA were more obese, more often smokers, and more frequently had a diagnosis of pregestational hypertension and diabetes mellitus. Increased risks in PsA pregnancies versus non-PsA pregnancies were primarily preterm birth (adjusted OR 1.69 [95% CI 1.27-2.24]) and cesarean delivery (adjusted OR 1.77 [95% CI 1.43-2.20] for elective delivery, and adjusted OR 1.42 [95% CI 1.10-1.84] for emergency delivery). The risks differed according to the presence, timing, and type of antirheumatic treatment, with the most increased risk in PsA pregnancies (versus non-PsA) occurring with antirheumatic treatment during pregnancy (adjusted OR 2.30 [95% CI 1.49-3.56] for preterm birth). The corresponding adjusted OR for preterm birth in women with PsA who were exposed specifically to biologic treatment during pregnancy was 4.49 [95% CI 2.60-7.79]. Risk of preterm birth was primarily increased in first pregnancies. CONCLUSION: Compared to non-PsA pregnancies, risks of preterm birth and cesarean delivery were mostly increased in those exposed to antirheumatic treatment during pregnancy, especially biologic treatments. As parity influences the risk of preterm birth in women with PsA, special attention to first pregnancies is warranted. Women with PsA should receive individualized monitoring during pregnancy.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Remaeus K, Johansson K, Granath F, et al. Pregnancy Outcomes in Women With Psoriatic Arthritis in Relation to Presence and Timing of Antirheumatic Treatment. Arthritis Rheumatol. 2022. PMID: 34668647. doi:10.1002/art.41985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。